Statins for Kidney Disease Patients
Author Information
Author(s): Navaneethan Sankar D, Pansini Francesca, Strippoli Giovanni F. M
Hypothesis
Is the use of statins in patients with chronic kidney disease supported by the available randomized clinical trial evidence?
Conclusion
Statins are effective in improving cholesterol levels in patients with chronic kidney disease, but their impact on overall mortality is still uncertain.
Supporting Evidence
- Statins reduced total cholesterol and LDL cholesterol levels in patients with chronic kidney disease.
- Statins have been recommended for use in patients on dialysis despite limited evidence.
- The 4D trial found no significant difference in cardiovascular mortality for diabetic patients on dialysis receiving statins.
Takeaway
Statins can help lower cholesterol in people with kidney problems, but we don't know if they help them live longer.
Methodology
The article reviews systematic reviews and randomized clinical trials regarding statin use in patients with chronic kidney disease.
Potential Biases
Some observational studies may have biased results regarding cholesterol levels and mortality.
Limitations
The evidence base is limited, with few and small trials, and many studies focus only on surrogate endpoints rather than mortality.
Participant Demographics
Patients with chronic kidney disease, including those on dialysis and predialysis.
Statistical Information
P-Value
0.03
Confidence Interval
95% CI, 0.68–0.99
Statistical Significance
p=0.03
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website